Mr. Burke acted as lead advisor to GlaxoSmithKline on the landmark bribery case against GSK in China, the first criminal case against a foreign company in China. Mr. Burke has also been engaged by leading multinationals with respect to compliance and investigations throughout Asia, including LVMH, McDonald’s, Olympus, Medtronic, Roche, Amgen, PetroChina, Volvo, Sephora, Valeo and many others. Mr. Burke divides his time between New York and China.
Mr. Burke regularly appears before the U.S. Department of Justice, U.S. Securities and Exchange Commission, UK Serious Fraud Office, Hong Kong Securities and Futures Commission and other U.S. and international regulators on cross-border investigations and compliance matters. Mr. Burke has also defended over a dozen Asia-based companies and individuals in U.S. securities class actions and shareholder derivative cases.